Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Chronic Lung Disease of Prematurity: early-phase trial registry

1 of 2 indexed Chronic Lung Disease of Prematurity trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Chronic Lung Disease of Prematurity: 2 US clinical trials tracked, 1 recruiting.

Chronic Lung Disease of Prematurity is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Lawrence Rhein, running 1 of these trials.

Enrollment posture brief

Registry condition chronic-lung-disease-of-prematurity

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Chronic Lung Disease of (th…50%
Open-enrollment share among volume-matched conditions near Chronic Lung Disease of Prematurity

Chronic Lung Disease of Prematurity lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chronic Lung Disease of Prematurity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chronic Lung Disease of Prematurity is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Lawrence Rhein 1 trials
OHB Neonatology 1 trials

Named interventions

Most-linked intervention names on Chronic Lung Disease of Prematurity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Sentec Digital Monitoring System (transcutaneous CO2 monitor) Device
1 trials
Sentec LuMon Device (EIT system) Device
1 trials
OHB-607 Drug
1 trials

US sites by state

Facility locations filed on Chronic Lung Disease of Prematurity trials. A trial with sites in several states counts in each.

Massachusetts 2 trials
Oklahoma 1 trials
Ohio 1 trials
New York 1 trials
Mississippi 1 trials
Minnesota 1 trials
Louisiana 1 trials
Kentucky 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chronic Lung Disease of Prematurity page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Chronic Lung Disease of Prematurity trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Lawrence Rhein sponsors the most Chronic Lung Disease of Prematurity trials on record, review their full trial history before evaluating a specific study. See Lawrence Rhein's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Lung Disease of Prematurity condition card totals 2 registered trials; most-linked intervention Sentec Digital Monitoring System (transcutaneous CO2 monitor); top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.